Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 22.0218.3016.1727.996.60

What is the latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS is 22.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202522.02
Mar202418.30
Mar202316.17
Mar202227.99
Mar20216.60

How is EV/Core EBITDA of JAGSONPAL PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 22.02
20.33
Mar2024 18.3
13.17
Mar2023 16.17
-42.23
Mar2022 27.99
324.09
Mar2021 6.6 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,439.5 Cr 7.9% -3.2% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

7.9%

-3.2%

-26.9%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses